FONT-SIZE Plus   Neg

CytomX Therapeutics Holding On To Strong Gain In Late-Day Trading

Shares of CytomX Therapeutics (CTMX) have pulled back off their highs of the session but continue to significant strength in late-day trading on Wednesday. After reaching its best intraday level in well over a year, CytomX is currently up by 20.5 percent.

The jump by CytomX comes after the biopharmaceutical company announced it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
KMG Chemicals Inc. (KMG) is likely to beat earnings per share or EPS estimates, when it reports first quarter results on December 11, after the bell. First quarter results of KMG are expected to benefit from the impact of Irma and Harvey, and early October fires in the West. Sysco Corp. is looking ahead to own 50 fully electric semi tracks to be launched by Tesla. The new electric tractors could run 500 miles on a single charging. The order from the food service distribution giant that owns more than 7000 trucks is worth up to $10 million. Patreon, the crowdfunding platform for artists, announced Wednesday a change in its payment structure that it says will help creators keep more money. Meanwhile, many are concerned that the change may discourage their patrons from pledging.
comments powered by Disqus
Follow RTT